#USA #San Antonio #organ transplantation #Vascular Perfusion Solutions #Dr. Hassan Tetteh

Vascular Perfusion Solutions Welcomes Dr. Hassan A. Tetteh as Chairman of the Board

Vascular Perfusion Solutions, Inc. (VPS), a trailblazing medical device firm headquartered in San Antonio, Texas, has announced the appointment of Dr. Hassan A. Tetteh as its new Chairman of the Board. This significant change comes as the company gears up for monumental strides in the medical field, particularly in the transplantation arena.

A Pivotal Appointment

As VPS prepares to launch its first-in-human program, Dr. Tetteh's extensive background in transplant surgery and organ recovery positions him as a vital leader during this transformative stage for the company. The VP.S ENCORE® is VPS's innovative portable hypothermic oxygenated perfusion (HOPE) platform, developed for the preservation and transport of donor organs. Dr. Rafael J. Veraza, the CEO and President of VPS, expressed confidence in Dr. Tetteh, noting, “Dr. Tetteh has spent his career at the intersection of transplant surgery, technology, and servitude—an alignment that embodies the ethos of VPS.”

Dr. Tetteh, a Brooklyn native, boasts an impressive professional pedigree. He is a board-certified thoracic, general, and clinical informatics surgeon as well as a retired Captain in the U.S. Navy, where he dedicated over 25 years, performing combat trauma surgery in Afghanistan. His leadership was evident in his founding of Specialized Thoracic Adapted Recovery (STAR) Teams, Inc., which was later acquired by a notable medical device enterprise. Currently, he is the Vice President of Vituity Organ Recovery, orchestrating organ recovery operations for one of the largest physician-led healthcare organizations in the nation.

Broadening Horizons in Organ Recovery

Dr. Tetteh's commitment to innovation in healthcare extends to his involvement in artificial intelligence in the medical field. He has served as Warfighter Health Mission Chief at the Department of Defense Joint Artificial Intelligence Center (JAIC) and has contributed as an AI strategist for the Department of Defense Chief Data and AI Office (CDAO). His qualifications, including MD, MPA, MBA, and MS degrees, along with fellowships in the American College of Surgeons and the American Medical Informatics Association, underscore his commitment to advancing healthcare technology.

“I am honored to serve as Chairman,” Dr. Tetteh remarked, recognizing the significant impact of VPS’s work. “VPS is addressing one of the most pressing and often overlooked issues in transplantation—how to effectively preserve and transport the gift of life so that more patients, including children and those in underserved communities, can access transplants.”

This mantra for equity and accessibility in organ transplantation resonates deeply with VPS's mission to make donor organ preservation simpler and more affordable. As Dr. Tetteh assumes his new role, he will provide essential governance and strategic direction as VPS edges closer to its groundbreaking efforts to utilize the VP.S ENCORE® in pediatric and underutilized heart cases.

The Future Looks Bright for VPS

The VP.S ENCORE® platform represents a transformational approach to organ preservation. It incorporates a reusable Base Unit, a single-use Perfusion Cassette, and organ-specific Cannula Kits, embodying an innovative, practical design for multiple organ types. The system, which was awarded FDA Breakthrough Device Designation in 2021, is engineered for expedience and effectiveness, promising to revolutionize organ transport logistics.

VPS’s research pipeline includes not only advancements in heart preservation but also focuses on kidney and multi-organ preservation methodologies, reinforcing invaluable contributions to life-saving medical technology. Dr. Tetteh’s leadership in this journey signals a new era for VPS and the broader healthcare community, emphasizing not just innovation, but a deep commitment to humanity.

In conclusion, as Vascular Perfusion Solutions embarks on this significant chapter under Dr. Tetteh’s stewardship, the expectation is not only to refine the science of organ preservation but also to ensure that every deserving patient is granted a fair chance at receiving the gift of life they so deeply need.